Sign in
8-K

Current Report

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-018934

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading cont20240524_8k.htm…